A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

NCT06595238 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

262

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity or Overweight

Interventions

DRUG: AZD6234
DRUG: Placebo comparator

Sponsor

AstraZeneca